New Delhi: Hyderabad-based Dr. Reddy’s Laboratory has obtained the approval of the Controller General of Indian Medicine (DCGI) to obtain the Phase III clinical trial approval on the human body of the Russian Corona vaccine Sputnik-5. ) Has applied. Sources gave this information. India’s leading pharma company has tied up with the Russian Direct Investment Fund (RDIF) for clinical trials and delivery of the vaccine.
The company said last month that RDIF will send 10 million doses of the vaccine to Doctor Reddy after getting DCGI approval. “Dr Reddy’s has applied to DCGI for approval of Phase III clinical trial on human body of Russia-developed Covid-19 vaccine Sputnik-5,” a source told PTI. DCGI will do a technical evaluation of the application before approving it. ”
